Cellceutix Signs Agreement with Girindus for Kevetrin(tm) API  
8/17/2009 10:07:47 AM

BEVERLY, Mass., Aug. 17, 2009 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCBB:CTIX), a bio-pharmaceutical company in the business of developing small-molecule therapies in areas of unmet medical needs, today announced that it has signed an agreement with Girindus America, Inc., for the manufacture of Kevetrin active pharmaceutical ingredient. Terms of the agreement were not disclosed.